Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
$79.65
-1.7%
$79.29
$66.49
$87.72
$74.66B1.072.81 million shs1.55 million shs
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
$10.30
+0.3%
$10.12
$9.22
$14.63
$1.23B1.032.16 million shs1.84 million shs
DexCom, Inc. stock logo
DXCM
DexCom
$82.94
+0.0%
$83.49
$57.52
$117.19
$32.52B1.444.41 million shs2.78 million shs
Hess Corporation stock logo
HES
Hess
$143.30
-0.5%
$136.07
$123.79
$161.69
$44.55B0.621.81 million shs2.92 million shs
Kansas City Southern stock logo
KSU
Kansas City Southern
$293.59
$297.85
$190.64
$315.39
$26.71B1.11.25 million shs40.68 million shs
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$8.43
-3.5%
$8.98
$5.04
$15.36
$438.40M1.06929,241 shs679,975 shs
TransUnion stock logo
TRU
TransUnion
$91.55
-0.1%
$86.95
$66.38
$113.17
$17.87B1.631.79 million shs1.49 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
-1.80%+0.44%-2.72%+18.59%-0.71%
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
+0.19%+3.83%+0.59%-12.34%-8.44%
DexCom, Inc. stock logo
DXCM
DexCom
+0.25%-4.98%-4.30%+36.66%-27.05%
Hess Corporation stock logo
HES
Hess
+0.62%+3.27%+5.38%+12.41%-2.44%
Kansas City Southern stock logo
KSU
Kansas City Southern
0.00%0.00%0.00%0.00%0.00%
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
-3.44%+2.68%-12.28%+58.76%-22.66%
TransUnion stock logo
TRU
TransUnion
-0.07%+3.98%+6.21%+32.30%+20.07%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
4.2849 of 5 stars
3.33.01.70.64.01.71.3
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
4.3785 of 5 stars
3.32.00.04.72.01.71.9
DexCom, Inc. stock logo
DXCM
DexCom
4.8942 of 5 stars
3.55.00.04.72.92.51.9
Hess Corporation stock logo
HES
Hess
4.8688 of 5 stars
3.34.02.51.22.62.53.1
Kansas City Southern stock logo
KSU
Kansas City Southern
N/AN/AN/AN/AN/AN/AN/AN/A
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
4.4642 of 5 stars
3.43.00.04.62.13.30.6
TransUnion stock logo
TRU
TransUnion
4.5745 of 5 stars
2.35.01.74.42.80.81.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
2.63
Moderate Buy$90.9514.18% Upside
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
2.50
Moderate Buy$24.00133.01% Upside
DexCom, Inc. stock logo
DXCM
DexCom
2.95
Moderate Buy$98.5018.76% Upside
Hess Corporation stock logo
HES
Hess
2.55
Moderate Buy$162.8613.65% Upside
Kansas City Southern stock logo
KSU
Kansas City Southern
0.00
N/AN/AN/A
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
2.83
Moderate Buy$31.63275.15% Upside
TransUnion stock logo
TRU
TransUnion
2.57
Moderate Buy$109.6919.82% Upside

Current Analyst Ratings Breakdown

Latest TRU, CP, DVAX, HES, DXCM, RGNX, and KSU Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/2/2025
Hess Corporation stock logo
HES
Hess
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$147.00 ➝ $153.00
6/26/2025
Hess Corporation stock logo
HES
Hess
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$193.00 ➝ $184.00
6/24/2025
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingPositive ➝ Positive$90.00 ➝ $94.00
6/16/2025
DexCom, Inc. stock logo
DXCM
DexCom
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$102.00
6/11/2025
Hess Corporation stock logo
HES
Hess
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$163.00 ➝ $173.00
6/9/2025
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$52.00
6/2/2025
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral$91.00
5/30/2025
DexCom, Inc. stock logo
DXCM
DexCom
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$104.00
5/22/2025
DexCom, Inc. stock logo
DXCM
DexCom
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$82.00 ➝ $102.00
5/22/2025
TransUnion stock logo
TRU
TransUnion
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$96.00 ➝ $100.00
5/16/2025
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$82.00 ➝ $90.00
(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
$10.62B6.91$4.51 per share17.66$38.22 per share2.08
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
$294.62M4.20$0.16 per share64.86$4.54 per share2.27
DexCom, Inc. stock logo
DXCM
DexCom
$4.15B7.84$2.25 per share36.90$5.38 per share15.42
Hess Corporation stock logo
HES
Hess
$13.02B3.40$17.67 per share8.11$38.96 per share3.68
Kansas City Southern stock logo
KSU
Kansas City Southern
$2.63B10.15$10.98 per share26.74$48.19 per share6.09
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$83.33M5.07N/AN/A$5.24 per share1.61
TransUnion stock logo
TRU
TransUnion
$4.18B4.27$6.22 per share14.71$22.16 per share4.13
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
$2.71B$2.9626.9120.272.2725.99%8.68%4.79%7/29/2025 (Estimated)
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
$27.31M-$0.52N/A21.02N/A-20.39%3.59%2.20%8/5/2025 (Estimated)
DexCom, Inc. stock logo
DXCM
DexCom
$576.20M$1.3461.9033.721.7712.90%30.05%10.00%7/30/2025 (Estimated)
Hess Corporation stock logo
HES
Hess
$2.77B$7.2319.8212.46N/A17.65%21.78%9.72%7/30/2025 (Estimated)
Kansas City Southern stock logo
KSU
Kansas City Southern
$617M$1.02287.8430.17N/A3.33%16.69%7.02%N/A
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
-$227.10M-$3.11N/AN/AN/A-100.62%-53.29%-30.84%8/7/2025 (Estimated)
TransUnion stock logo
TRU
TransUnion
$284.30M$1.8848.7019.032.538.63%16.18%6.38%7/24/2025 (Estimated)

Latest TRU, CP, DVAX, HES, DXCM, RGNX, and KSU Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
$0.12N/AN/AN/A$87.55 millionN/A
7/30/2025Q2 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.45N/AN/AN/A$1.13 billionN/A
7/30/2025Q2 2025
Hess Corporation stock logo
HES
Hess
$1.22N/AN/AN/A$2.69 billionN/A
7/29/2025Q2 2025
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
$0.82N/AN/AN/A$2.76 billionN/A
7/24/2025Q2 2025
TransUnion stock logo
TRU
TransUnion
$0.99N/AN/AN/A$1.10 billionN/A
5/12/2025Q1 2025
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$0.41$0.12-$0.29$0.12$105.35 million$89.01 million
5/6/2025Q1 2025
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
$0.03-$0.11-$0.14-$0.77$70.01 million$68.16 million
5/1/2025Q1 2025
DexCom, Inc. stock logo
DXCM
DexCom
$0.33$0.32-$0.01$0.27$1.02 billion$1.04 billion
4/30/2025Q1 2025
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
$0.74$0.74N/A$0.68$2.56 billion$2.66 billion
4/30/2025Q1 2025
Hess Corporation stock logo
HES
Hess
$1.95$1.81-$0.14$1.39$2.95 billion$2.92 billion
4/24/2025Q1 2025
TransUnion stock logo
TRU
TransUnion
$0.98$1.05+$0.07$0.75$1.07 billion$1.10 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
$0.660.83%N/A22.30%N/A
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
N/AN/AN/AN/AN/A
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Hess Corporation stock logo
HES
Hess
$2.001.40%N/A27.66%3 Years
Kansas City Southern stock logo
KSU
Kansas City Southern
$2.160.74%N/A211.77%N/A
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
N/AN/AN/AN/AN/A
TransUnion stock logo
TRU
TransUnion
$0.460.50%N/A24.47%1 Years

Latest TRU, CP, DVAX, HES, DXCM, RGNX, and KSU Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2025
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
quarterly$0.16440.8%6/27/20256/27/20257/28/2025
5/14/2025
Hess Corporation stock logo
HES
Hess
quarterly$0.501.49%6/16/20256/16/20256/30/2025
5/8/2025
TransUnion stock logo
TRU
TransUnion
quarterly$0.11500.54%5/22/20255/22/20256/6/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
0.43
0.81
0.70
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
0.49
11.93
10.84
DexCom, Inc. stock logo
DXCM
DexCom
0.55
1.50
1.32
Hess Corporation stock logo
HES
Hess
0.71
1.08
0.91
Kansas City Southern stock logo
KSU
Kansas City Southern
0.89
0.72
0.62
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
N/A
2.93
2.93
TransUnion stock logo
TRU
TransUnion
1.13
2.05
2.05

Institutional Ownership

CompanyInstitutional Ownership
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
72.20%
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
96.96%
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Hess Corporation stock logo
HES
Hess
88.51%
Kansas City Southern stock logo
KSU
Kansas City Southern
79.69%
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
88.08%
TransUnion stock logo
TRU
TransUnion
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Canadian Pacific Kansas City Limited stock logo
CP
Canadian Pacific Kansas City
19,797921.41 million921.32 millionOptionable
Dynavax Technologies Corporation stock logo
DVAX
Dynavax Technologies
350120.08 million116.50 millionOptionable
DexCom, Inc. stock logo
DXCM
DexCom
10,300392.11 million390.85 millionOptionable
Hess Corporation stock logo
HES
Hess
1,797309.31 million281.16 millionOptionable
Kansas City Southern stock logo
KSU
Kansas City Southern
6,52290.98 million90.23 millionOptionable
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
37050.16 million43.75 millionOptionable
TransUnion stock logo
TRU
TransUnion
13,400195.10 million194.61 millionOptionable

Recent News About These Companies

Study: Filipinos cut back, save more amid inflation
TransUnion (NYSE:TRU) Rating Increased to Buy at Wall Street Zen

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Canadian Pacific Kansas City stock logo

Canadian Pacific Kansas City NYSE:CP

$79.65 -1.38 (-1.70%)
Closing price 07/7/2025 03:58 PM Eastern
Extended Trading
$79.66 +0.00 (+0.01%)
As of 07/7/2025 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Canadian Pacific Kansas City Limited, together with its subsidiaries, owns and operates a transcontinental freight railway in Canada, the United States, and Mexico. The company transports bulk commodities, including grain, coal, potash, fertilizers, and sulphur; merchandise freight, such as forest products, energy, chemicals and plastics, metals, minerals, consumer products, and automotive; and intermodal traffic comprising retail goods in overseas containers. It also provides rail and intermodal transportation services over a network of approximately 20,000 miles serving business centres. The company was formerly known as Canadian Pacific Railway Limited and changed its name to Canadian Pacific Kansas City Limited in April 2023. Canadian Pacific Kansas City Limited was incorporated in 1881 and is headquartered in Calgary, Canada.

Dynavax Technologies stock logo

Dynavax Technologies NASDAQ:DVAX

$10.30 +0.03 (+0.29%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$10.30 +0.00 (+0.05%)
As of 07/7/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.

DexCom stock logo

DexCom NASDAQ:DXCM

$82.94 +0.01 (+0.01%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$82.68 -0.25 (-0.31%)
As of 07/7/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Hess stock logo

Hess NYSE:HES

$143.30 -0.73 (-0.51%)
Closing price 07/7/2025 03:58 PM Eastern
Extended Trading
$142.25 -1.05 (-0.73%)
As of 07/7/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Hess Corporation, an exploration and production company, explores, develops, produces, purchases, transports, and sells crude oil, natural gas liquids (NGLs), and natural gas. The company operates in two segments, Exploration and Production, and Midstream. It conducts production operations primarily in the United States, Guyana, the Malaysia/Thailand Joint Development Area, and Malaysia; and exploration activities principally offshore Guyana, the U.S. Gulf of Mexico, and offshore Suriname and Canada. The company is also involved in gathering, compressing, and processing natural gas; fractionating NGLs; gathering, terminaling, loading, and transporting crude oil and NGL through rail car; and storing and terminaling propane, as well as providing water handling services primarily in the Bakken Shale plays in the Williston Basin area of North Dakota. The company was incorporated in 1920 and is headquartered in New York, New York.

Kansas City Southern stock logo

Kansas City Southern NYSE:KSU

Kansas City Southern is a transportation holding company. It focuses on the growing north or south freight corridor connecting key commercial and industrial markets in the central United States with major industrial cities in Mexico. The firm also engages in the freight rail transportation business operating through a single coordinated rail network. The company was founded by Arthur E. Stilwell in 1887 and is headquartered in Kansas City, MO.

REGENXBIO stock logo

REGENXBIO NASDAQ:RGNX

$8.43 -0.31 (-3.55%)
As of 07/7/2025 04:00 PM Eastern

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase I/II clinical trial for the treatment of Duchenne muscular dystrophy. It also develops RGX-121 for the treatment of mucopolysaccharidosis type II that is in Phase III clinical trial; RGX-111 for treating mucopolysaccharidosis type I; RGX-181 for the treatment of late infantile neuronal ceroid lipofuscinosis type II; and RGX-381 to treat the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.

TransUnion stock logo

TransUnion NYSE:TRU

$91.55 -0.06 (-0.07%)
Closing price 07/7/2025 03:58 PM Eastern
Extended Trading
$91.40 -0.15 (-0.16%)
As of 07/7/2025 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TransUnion operates as a global consumer credit reporting agency that provides risk and information solutions. The company operates through U.S. Markets, International, and Consumer Interactive segments. The U.S. Markets segment provides consumer reports, actionable insights, and analytic services to businesses, which uses its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk. This segment serves various industry vertical markets, including financial services, technology, commerce and communications, insurance, media, services and collections, tenant and employment, and public sectors. The International segment offers credit reports, analytics, technology solutions, and other value-added risk management services; consumer services, which help consumers to manage their personal finances; consumer credit reporting, insurance and auto information solutions, and commercial credit information services. It serves customers in financial services, retail credit, insurance, automotive, collections, public sector, and communications industries through direct and indirect channels. The company was formerly known as TransUnion Holding Company, Inc. and changed its name to TransUnion in March 2015. TransUnion was founded in 1968 and is headquartered in Chicago, Illinois.